نتائج البحث

تحتوي على الكلمات

فقط من النوع

A Phase III, Double-Blind, Randomised Study to Assess the Efficacy and Safety of AZD9291 versus a Standard of Care Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with Epidermal Growth Factor Receptor Mutation Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer قائمة الدراسات السريرية المسجلة على الادوية

مقارنة بين عقار الانترفيرون بيتا 1 (Interferon beta-1a) وعقار الجلاتيرامر اسيتيت (glatiramer acetate) لعلاج مرض (relapsing-remitting multiple sclerosis) المقالات التوعوية

A randomized, double-blinded placebo-controlled, phase 3, parallel-group design study evaluating the efficacy and safety of Efgartigimod PH20 SC Administered by prefilled syringe in adults participants with ocular MG قائمة الدراسات السريرية المسجلة على الادوية

C Chauvoei/ C Septicum/C novyi/ C Sordellii/ C perfringes type C Strain PC8/C perfringes type D Strain317/ C harmolyticum/M haemolytica Type A1 قائمة الأدوية تحت التسجيل / قائمة الأدوية المعروضة على لجنة التسجيل

Phase 3b, Open-label, Multicenter, Single-dose Study Investigating Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy Administered to Adult Subjects with Severe or Moderately Severe Hemophilia B with Detectable Pretreatment AAV5 Neutralizing Antibodies قائمة الدراسات السريرية المسجلة على الادوية

A 2-Part, Open-Label, Phase 2, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of Patiromer in Children under 12 Years of Age with Hyperkalaemia (EMERALD2) قائمة الدراسات السريرية المسجلة على الادوية

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy and Safety of RZ358 in Patients with Congenital Hyperinsulinism قائمة الدراسات السريرية المسجلة على الادوية

A randomized, double-blind, Phase 3 study comparing efficacy and safety of frexalimab (SAR441344) to placebo in adult participants with nonrelapsing secondary progressive multiple sclerosis. قائمة الدراسات السريرية المسجلة على الادوية

A Phase 3, randomized, double-blind, placebo-controlled, parallel-group, 3-arm, multinational, multicenter study to evaluate the efficacy and safety of amlitelimab by subcutaneous injection in participants aged 18 years and older with moderate-to-severe atopic dermatitis (AD) who are on background topical corticosteroids and have had an inadequate response to prior biologic therapy or oral Janus Kinase (JAK) inhibitor treatment قائمة الدراسات السريرية المسجلة على الادوية

CAMBRIA-2: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients with ER+/HER2- Early Breast Cancer and an Intermediate-High or High Risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease قائمة الدراسات السريرية المسجلة على الادوية